NuCana Future Growth
Future criteria checks 0/6
NuCana is forecast to grow earnings and revenue by 10.2% and 79.1% per annum respectively while EPS is expected to grow by 20.4% per annum.
Key information
10.2%
Earnings growth rate
20.4%
EPS growth rate
| Biotechs earnings growth | 27.1% |
| Revenue growth rate | 79.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Oct 2024 |
Recent future growth updates
Recent updates
Can NuCana (NASDAQ:NCNA) Afford To Invest In Growth?
Aug 21
Here's Why NuCana (NASDAQ:NCNA) Must Use Its Cash Wisely
Mar 14We're Keeping An Eye On NuCana's (NASDAQ:NCNA) Cash Burn Rate
Oct 15Here's Why We're A Bit Worried About NuCana's (NASDAQ:NCNA) Cash Burn Situation
Jul 01Here's Why We're Watching NuCana's (NASDAQ:NCNA) Cash Burn Situation
Mar 15Here's Why We're Watching NuCana's (NASDAQ:NCNA) Cash Burn Situation
Nov 30NuCana: An Intriguing 'Sum Of The Parts' Story
Sep 22NuCana GAAP EPS of -£0.07
Aug 17NuCana regains Nasdaq compliance
Jul 27NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead
Jul 13Here's Why We're Watching NuCana's (NASDAQ:NCNA) Cash Burn Situation
May 02We Think NuCana (NASDAQ:NCNA) Can Easily Afford To Drive Business Growth
Jan 17NuCana: Preparing For A Critical 2022
Dec 08We're Interested To See How NuCana (NASDAQ:NCNA) Uses Its Cash Hoard To Grow
Sep 30NuCana: The Market Continues To Overlook Its ProTide Platform Technology
Sep 11We Think NuCana (NASDAQ:NCNA) Can Afford To Drive Business Growth
Jun 01Companies Like NuCana (NASDAQ:NCNA) Are In A Position To Invest In Growth
Feb 15How Many NuCana plc (NASDAQ:NCNA) Shares Do Institutions Own?
Dec 22
NuCana (NCNA) Investor Presentation - Slideshow
Dec 02NuCana reports Q3 results
Nov 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -27 | N/A | N/A | 4 |
| 12/31/2025 | N/A | -24 | N/A | N/A | 4 |
| 12/31/2024 | N/A | -25 | N/A | N/A | 4 |
| 6/30/2024 | N/A | -28 | -18 | -17 | N/A |
| 3/31/2024 | N/A | -27 | -22 | -22 | N/A |
| 12/31/2023 | N/A | -28 | -27 | -26 | N/A |
| 9/30/2023 | N/A | -35 | -34 | -33 | N/A |
| 6/30/2023 | N/A | -33 | -22 | -22 | N/A |
| 3/31/2023 | N/A | -31 | -25 | -25 | N/A |
| 12/31/2022 | N/A | -32 | -24 | -23 | N/A |
| 9/30/2022 | N/A | -30 | -27 | -26 | N/A |
| 6/30/2022 | N/A | -34 | -30 | -29 | N/A |
| 3/31/2022 | N/A | -39 | -25 | -24 | N/A |
| 12/31/2021 | N/A | -41 | -25 | -24 | N/A |
| 9/30/2021 | N/A | -39 | -23 | -23 | N/A |
| 6/30/2021 | N/A | -40 | -28 | -27 | N/A |
| 3/31/2021 | N/A | -36 | -25 | -23 | N/A |
| 12/31/2020 | N/A | -31 | -23 | -22 | N/A |
| 9/30/2020 | N/A | -26 | -18 | -17 | N/A |
| 6/30/2020 | N/A | -22 | -21 | -20 | N/A |
| 3/31/2020 | N/A | -20 | -25 | -24 | N/A |
| 12/31/2019 | N/A | -21 | -25 | -24 | N/A |
| 9/30/2019 | N/A | -17 | -24 | -22 | N/A |
| 6/30/2019 | N/A | -16 | -19 | -18 | N/A |
| 3/31/2019 | N/A | -13 | -17 | -16 | N/A |
| 12/31/2018 | N/A | -14 | -14 | -12 | N/A |
| 9/30/2018 | N/A | -15 | -14 | -13 | N/A |
| 6/30/2018 | N/A | -26 | -12 | -11 | N/A |
| 3/31/2018 | N/A | -28 | N/A | -10 | N/A |
| 12/31/2017 | N/A | -23 | N/A | -9 | N/A |
| 9/30/2017 | N/A | -20 | N/A | -8 | N/A |
| 6/30/2017 | N/A | -7 | N/A | -8 | N/A |
| 3/31/2017 | N/A | -6 | N/A | -9 | N/A |
| 12/31/2016 | N/A | -6 | N/A | -9 | N/A |
| 12/31/2015 | N/A | -5 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NCNA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NCNA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NCNA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NCNA is forecast to have no revenue next year.
High Growth Revenue: NCNA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NCNA's Return on Equity is forecast to be high in 3 years time